Kyntra Bio, Inc. (KYNB) Tops Q2 EPS by 614c

Kyntra Bio, Inc. (NASDAQ: KYNB) reported Q2 EPS of $2.96, $6.14 better than the analyst estimate of ($3.18).

For earnings history and earnings-related data on Kyntra Bio, Inc. (KYNB) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• AXIL Brands (AXIL) Tops Q4 EPS by 4c
• Mercury Systems (MRCY) Misses Q4 EPS by 2c